Meeting
2024 ASCO Genitourinary Cancers Symposium
Germline mutations in patients with metastatic prostate cancer: A prospective cohort study in South Korea (KCSG GU20-19).
Authors
Joo-Hwan Park
Division of Medical Oncology, Department of Internal Medicine, Gachon University School of Medicine, Gil Medical Center, Incheon, South Korea
Joo-Hwan Park , Inkeun Park , Jinju Kim , Chang Seon Lee , Kwonoh Park , Jin Young Kim , Se Hyun Kim , Il Hwan Kim , Hyo Jin Lee , Woo Kyun Bae , Seok Jae Huh , Miso Kim , Min-Young Lee , Seong Hoon Shin , Ho Young Kim , Byeong Seok Sohn , In-Ho Kim , Jae-Lyun Lee
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 4; abstr 193)
DOI
10.1200/JCO.2024.42.4_suppl.193
Abstract #
193
Poster Bd #
H22
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
The spectrum of homologous recombination deficiency in cervical cancer: Is it also a cervical issue?
First Author: Muhammad Danyal Ahsan
Poster
2023 ASCO Annual Meeting
A four-tier classification system for studying homologous recombination repair gene reversion mutations as a mechanism of resistance to PARP inhibitors and platinum chemotherapy.
First Author: Qiuxiang Ou
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Prevalence of germline mutations and homologous recombination deficiency (HRD) in a real-world biliary tract cancer (BTC) cohort.
First Author: Robin Kate Kelley
Poster
2021 ASCO Annual Meeting
Pan-cancer evaluation of homologous repair deficiency somatic mutations and response to first-line anti-neoplastic therapy.
First Author: Jessica A Lavery